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Abstract 
Introduction 
Chronic disease risk may be high in people with multiple sclerosis (MS). Our objective was to identify chronic health 
conditions that may disproportionately affect male veterans with MS. 
Methods 
We collected primary survey data for male veterans with MS (n = 1,142) in 2003 and 2004 and compared the data with 
2003 Behavioral Risk Factor Surveillance System secondary data for comparison groups without MS (veteran 
population, n = 31,500; general population = 68,357). We compared disease prevalence by group and identified 
variables associated with chronic diseases in male veterans with MS. 
Results 
Overall, veterans with MS had a high prevalence of hypercholesterolemia (49%), hypertension (47%), diabetes (16%), 
coronary heart disease (11%), and stroke (7%). Overall and for the subset of people aged 50 years or older, diabetes, 
hypertension, hypercholesterolemia, coronary heart disease, and stroke were significantly more prevalent among male 
veterans with MS than among the general population. Diabetes, hypertension, hypercholesterolemia, and stroke were 
more prevalent overall among male veterans with MS than among the general veteran population; however, except for 
stroke, differences were not significant for the group aged 50 or older. Explanatory variables (eg, age, education, race) 
and dynamic associations between conditions (higher odds for each when ≥1 of the other conditions were present) for 
chronic disease in men with MS were similar to findings in the general population literature for select conditions. 
Conclusion 
These findings raise awareness of chronic disease in a veteran cohort and help bridge a gap in the literature on chronic 
disease epidemiology in men with MS. We identified chronic disease priorities that may benefit from focused 
interventions to reduce disparities. 
Introduction 
How idiosyncratic changes related to a person’s primary disability, such as multiple sclerosis (MS), affect that person’s 
health and aging process is unclear. Research suggests that people with MS experience more premature illness (1,2), 
which may result in the presence of more chronic diseases at a younger age, compared with the general population. 
Factors such as inactivity and immobility may place people with MS at increased risk of developing disabilities, and 
they may be disproportionately affected by chronic diseases (1,2). Comprehensive research on chronic disease 
prevalence among people with MS is lacking, especially among men with MS, since MS is more prevalent in women 
(3). 
The Centers for Disease Control and Prevention (CDC) uses the Behavioral Risk Factor Surveillance System (BRFSS) to 
compile chronic disease prevalence data for the US population, but data specific to people with MS are unavailable. 
The Veterans Health Administration (VA) is a large health care system that provides care to approximately 28,000 
people with MS, a substantial proportion of whom are male (88%) (4). These VA data can provide needed 
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Our objective was to identify chronic diseases that may disproportionately affect male veterans with MS. Diabetes, 
hypertension, hypercholesterolemia, coronary heart disease (CHD), and stroke were assessed because they are 
associated with the leading causes of illness and death in the United States (5). 
Methods 
Design 
We collected primary data during 2003 and 2004 using a cross-sectional survey mailed to male veterans with MS. We 
obtained secondary data from the 2003 CDC BRFSS (6) to provide comparison group data for the general veteran 
population and general population. The institutional review board at the Hines VA Hospital and the Office for the 
Protection of Research Subjects at the University of Illinois at Chicago approved the study. 
We used similarly worded questions from CDC BRFSS modules (6) to design the 65-item Multiple Sclerosis Health 
Care Questionnaire (MS-HCQ) (survey instrument available on request from the corresponding author) to collect 
primary data on sociodemographics, health behaviors, and chronic disease prevalence in veterans with MS. We 
included additional questions to assess MS duration and age at diagnosis. 
The BRFSS survey is a standardized instrument used to monitor disease, health, and risk behaviors in the US 
population (50 states, the District of Columbia, Puerto Rico, Guam, and the US Virgin Islands). BRFSS data are 
collected annually from a probability sample of households with landline telephones. Trained interviewers conduct 
surveys by telephone. We obtained data from the 2003 BRFSS (6) for the general veteran population and general 
population comparison groups. Using formulas established by CDC, we weighted these data for selection probability 
(additional details may be found at www.cdc.gov/brfss/technical_infodata/weighting.htm). 
Sample 
VA researchers mailed surveys to a national cohort of veterans with MS who were members of a congressionally 
chartered veteran service organization (VSO). The sample included people with an MS diagnosis (confirmed by 
Veterans Benefits Department for VSO eligibility) who were both current users and nonusers of VA health care. We 
distributed surveys to 2,940 veterans with MS; 735 were returned undeliverable. A total of 1,305 veterans with MS (163 
women, 1,142 men) returned completed surveys, resulting in a 59% (1,305 of 2,205) response rate. 
There were 264,684 respondents to the 2003 BRFSS. We excluded data from 160,284 female respondents and 4,543 
respondents whose data for veteran status were missing. Therefore, our study sample for comparison groups included 
99,857 adult male respondents from the 2003 BRFSS. The general veteran population included respondents who 
served on active duty in the US Armed Forces and were retired or discharged from military service (n = 31,500); the 
remaining cohort comprised the male general population (n = 68,357). On the basis of Council of American Survey and 
Research Organizations guidelines, the 2003 BRFSS had a median response rate of 53% and a median interview 
completion rate of 77% (7). 
Variables 
Proportions of chronic disease prevalence were the main outcome measures, and these were determined by a yes 
response to questions asking whether they had ever been told by a health professional that they had the disease 
(diabetes, hypertension, hypercholesterolemia, CHD, or stroke). 
Sociodemographic variables were age (continuous), race/ethnicity (self-identified as non-Hispanic white, non-
Hispanic black or African American, Hispanic [any race], or other [Asian, Native Hawaiian/other Pacific Islander, 
American Indian or Alaska Native, or other]), education completed (<12 y, 12 y or equivalent, some college, or college 
graduate), employment status (employed, unemployed/able to work, unemployed/unable to work, or retired), marital 
status (married, divorced/separated, widowed, or never married), and geographic region of residence (South, West, 
Midwest, or Northeast, determined on the basis of US census regions using zip code). Health behavior variables were 
cigarette smoking (current, past, or never) and chronic drinking (having consumed ≥2 drinks/d in the past 30 days). 
Statistical analyses 
We calculated descriptive statistics for age at MS diagnosis (difference in MS diagnosis date and date of birth) and MS 
duration (difference in MS diagnosis date and survey return date). We conducted bivariate comparisons (t tests for 
continuous and Χ  tests for categorical variables) of male veterans with MS and each of the non-MS male comparison 
groups overall and for the subset of men aged 50 or older to assess differences between groups. We conducted 
multivariate analyses for the MS cohort for each chronic disease that resulted in significant bivariate associations 
between MS and both non-MS groups in the overall comparisons. 
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associated with the presence of each chronic disease in male veterans with MS. We built separate multivariate logistic 
regression models for diabetes, hypertension, hypercholesterolemia, and stroke, dichotomizing the dependent variable 
for each (disease present/not present). Covariates were age, race/ethnicity, age at MS diagnosis, education completed, 
employment status, marital status, region of residence, smoking and drinking status, and other chronic diseases. 
Because of large CDC sample sizes and the potential for significance of small differences, we used random samples to 
test the significance of bivariate prevalence associations between the MS cohort and each of the CDC comparison 
groups. Random samples of 1,500 were used for comparisons between the non-MS groups and the MS group (n = 
1,142), and random samples of 1,000 were used for the comparisons between the non-MS groups and the MS group (n 
= 962) for the subset aged 50 or older. To determine the random sample sizes, we calculated power using the Pearson 
Χ  test of 2 proportions (2-sided test, P < .05). We approximated numbers to attain 90% power and to detect a 5% 
difference in the number of people who had a chronic disease between the MS group and each non-MS group. 
We conducted a separate analysis to assess whether the VSO survey respondents with MS were representative of the 
larger population of veterans with MS. Using VA administrative databases, we captured demographic data for people 
with MS (according to the International Classification of Diseases, 9th Revision, diagnosis code 340) who had used 
the VA health care system during the data collection period. 
Significance was set at P < .05. We used SAS version 9.1 (SAS Institute, Inc, Cary, North Carolina) and Stata version 10 
software (StataCorp LP, College Station, Texas) for statistical analyses. 
Results 
Participant characteristics 
Mean age of MS diagnosis was 37 years, and the average number of years living with MS was 23. In each group, more 
than half of respondents were married, approximately one-third were college graduates, and the highest proportion of 
participants were white and resided in the South (Table 1). Compared with veterans with MS and the general veteran 
population, the general population was younger and a greater proportion was currently employed and never smoked. 
Chronic drinking was low among all groups, particularly among veterans with MS. 
Chronic diseases 
Prevalence of hypercholesterolemia, hypertension, diabetes, and stroke was higher among veterans with MS than 
among the general veteran and general populations (Table 2). Prevalence of CHD was significantly higher among 
veterans with MS than among the general population but not among the general veteran population. Among the subset 
of respondents aged 50 or older, prevalence of stroke was higher among veterans with MS than among the general 
veteran and general populations. Prevalence of CHD among respondents aged 50 or older was lower among veterans 
with MS than among the general veteran population and was higher among veterans with MS than among the general 
population. Prevalence of hypercholesterolemia, hypertension, and diabetes was significantly higher among veterans 
with MS only compared with the general population. 
Multivariate analyses showed that the odds of having diabetes were higher among male veterans with MS who were 
older, non-Hispanic black or African American (vs white), and past smokers (vs current smokers) and who had 
hypertension, hypercholesterolemia, or a prior stroke (Table 3). Male veterans with MS who were college graduates 
had lower odds of having diabetes than their counterparts who did not complete high school. Widowed male veterans 
with MS were more than 2.5 times as likely to have hypertension as male veterans with MS who were currently 
married. The odds of having hypertension among male veterans with MS were higher with comorbid diabetes, 
hypercholesterolemia, prior stroke, and CHD, as well as for chronic drinkers. 
Male veterans with MS who were non-Hispanic black or African American (vs white), lived in the Midwest (vs the 
South), or had a prior stroke had lower odds for hypercholesterolemia. The odds for hypercholesterolemia among male 
veterans with MS were higher with comorbid diabetes, hypertension, and CHD. Among male veterans with MS, the 
odds for having a stroke were lower with comorbid hypercholesterolemia but higher with concurrent asthma, CHD, 
diabetes, and hypertension. Older age at MS diagnosis was marginally associated with a higher risk of stroke. 
Statistical association and representativeness 
Presence or absence of significant associations remained across the 5 chronic diseases, with 1 exception: prevalence of 
diabetes was no longer significant in the MS population compared with the general veteran population (overall). VA 
administrative data showed comparable characteristics of veterans with MS (vs survey respondents): 86% male (vs 
88%), mean age of 58 years (vs 61 y), 85% white (vs 91%), and 65% married (vs 75%). 
Discussion 
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veterans with MS compared with population-based CDC surveillance data. 
Overall and for respondents aged 50 or older, diabetes, hypertension, hypercholesterolemia, CHD, and stroke were 
significantly more prevalent among male veterans with MS than among men in the general population. Likewise, 
diabetes, hypertension, hypercholesterolemia, and stroke were more prevalent, overall, in male veterans with MS than 
among the general veteran population, but only stroke was significantly more prevalent among the subset of 
respondents aged 50 or older. Although the higher prevalence of many chronic diseases in the MS cohort relative to the 
general population was anticipated, this study provided nationally representative estimates of the magnitude of these 
differences. 
Diabetes 
Some studies have reported lower diabetes prevalence among people with MS compared with other cohorts (8); others 
have reported higher diabetes prevalence among MS cohorts compared with the general population (9), which is 
consistent with our findings. Higher diabetes prevalence among people with MS may be attributable to muscle disease 
from nerve demyelination or to adrenocorticotropic hormone and glucocorticoid treatment (9). 
We found that male veterans with MS who graduated college were less likely to have diabetes than those with less 
education, which is supported by reports that men who did not finish high school were more likely to have self-
reported (10) and diagnosed (11) diabetes than those who had more education. We found that non-Hispanic black or 
African American male veterans with MS were nearly 3 times as likely as white male veterans with MS to have diabetes. 
This finding is similar to that of another study that found that black race was associated with increased odds of 
diabetes compared with white race but that controlling for education reduced the odds but retained significance (12). 
In veterans with MS, the disparity in diabetes risk for non-Hispanic black or African American men remained after 
controlling for education. 
Similar to general medical literature, higher odds for diabetes was associated with hypercholesterolemia (13), prior 
stroke (13), and hypertension (75% of people with type 2 diabetes have hypertension [14]). Much of the illness and 
death associated with diabetes and its complications can be prevented or delayed by normalizing blood glucose levels, 
blood pressure, and lipids (15). Some complications that diabetes may lead to, such as vision problems and limb 
amputation (due to poor circulation) (15), may be more debilitating for people with MS, who often have mobility 
limitations. Early efforts are needed to screen men with MS who have comorbid conditions that are known risk factors 
for diabetes, with special focus on non-Hispanic black or African American men and people with less education. 
Hypertension 
Male veterans with MS who were chronic drinkers had increased odds of having hypertension, a relationship that has 
been well documented in the general population (16). Consistent with general medical literature, odds for hypertension 
in this study were higher with comorbid diabetes (17), CHD (18,19), hyperlipidemia (20), and stroke (21). We found 
that widowed male veterans with MS were 2.5 times as likely to have hypertension as their counterparts who were 
married. Becoming widowed may alter peoples’ patterns of interaction in the health care system and informal care 
practices (eg, loss of a person who assists in care and supports self-care management); the associated negative health 
risks are elevated and long-term for widowed men (22). Not being married has been associated with poor adherence to 
taking hypertension medication (23). Furthermore, hypertension may be independently associated with an increased 
risk of ambulatory disability in people with MS (24), making it imperative to address to preserve function in this group. 
Hypercholesterolemia 
We found that non-Hispanic black or African American (vs white) race/ethnicity and residing in the Midwest (vs the 
South) were independently associated with lower odds of hypercholesterolemia in male veterans with MS. Gallup 
prevalence measures for hypercholesterolemia were comparable for both 2008 and 2009 (eg, white higher than black 
by ≥5 points and Midwest higher than South by ≥2 points) (25). Consistent with general medical literature, odds of 
hypercholesterolemia in men with MS were greater with CHD (26), hypertension (20), and diabetes (27). Studies have 
found different blood cholesterol and lipoprotein levels depending on the phase of clinical stability in which people 
with MS were (28), which may affect point prevalence values. Further understanding of the higher prevalence of 
hypercholesterolemia in veterans with MS is warranted, with special attention being paid to its presence in white men 
and people living in the South. 
Stroke 
People with MS may have a higher risk of stroke than people who do not have MS (29). Although the absolute value for 
stroke prevalence in our study was not alarming, disparities were evident across age groups in male veterans with MS 
compared with both non-MS groups. Comparable to general medical literature, odds of stroke were higher for people 
with diabetes (30,31), CHD (30), and hypertension (30). Stroke is a leading cause of death in people with MS (32) and 
is associated with high hospital use in people with MS (8). Strategies to raise awareness of increased stroke risk and 
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may be difficult to distinguish) would be beneficial. 
Limitations 
The moderate response rate (59%) for the cohort of veterans with MS may have introduced nonresponse bias. These 
self-reported data are subject to recall bias. Differences may exist in responses provided by mail (MS-HCQ) versus 
telephone interview (BRFSS), although comparisons of BRFSS data from the 2 survey modes are “largely 
equivalent” (33). The comparison groups identified using secondary BRFSS data may have included people with MS, as 
exclusion was not possible; however, given the small numbers of people with MS relative to the general veteran and 
general populations (<1%), it is unlikely that chance inclusion of people with MS would have modified any true effect. 
Data were not available on factors that may influence chronic disease prevalence, such as nutrition, physical activity, 
genetic risk, or exacerbation periods and MS subtype. Findings from this study may be more generalizable than those 
of other MS research because the MS cohort is not limited to clinical or patient study samples (which may limit 
external validity and generate selection bias). 
Conclusion 
Overall, diabetes, hypertension, hypercholesterolemia, and stroke were significantly more prevalent among male 
veterans with MS than among men in both comparison groups. Nearly half of male veterans with MS had 
hypercholesterolemia and hypertension; these conditions occurring alone or concomitantly are implicated in many 
other diseases and should be addressed. Although a lower proportion of men were affected by stroke, the prevalence 
was consistently disparate across age groups. Future studies to examine age at onset and chronic disease severity 
relative to age- and sex-matched controls are needed to provide knowledge about premature morbidity and aging in 
people with MS. Further research is needed to understand the effects of clusters of comorbidites in this cohort. 
Research on the epidemiology of multiple chronic diseases in MS is scarce, and our findings help bridge a literature 
gap. We identified chronic disease priorities among male veterans with MS that may be targeted for early intervention 
to improve health and reduce disparities in this population. 
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Characteristic
Overall Aged ≥50 Years
MS 
(n = 
1,142)
GV 
(n = 
31,500) P
GP (n = 
68,357) P
MS (n 
= 
962)
GV (n = 
25,055) P
GP (n = 
21,316) P
Mean age, y 60.8 59.1 .89 39.5 <.001 63.8 66.0 .79 60.5 .06
Race/ethnicity
Non-Hispanic white 91.0 81.4 <.001 66.6 <.001 92.8 85.6 <.001 73.1 <.001
Non-Hispanic 
black/African 
American
5.1 7.6 .002 8.7 <.001 4.2 5.6 .07 8.5 <.001
Hispanic, any race 2.7 5.8 <.001 16.4 <.001 2.1 4.5 <.001 11.5 <.001
Other 1.2 5.2 <.001 8.3 <.001 .9 4.3 <.001 6.9 <.001
Education completed
<12 y 4.1 7.3 <.001 13.8 <.001 4.5 8.5 <.001 17.4 <.001
12 y or equivalent 17.9 31.4 <.001 29.5 <.001 18.6 30.3 <.001 25.5 <.001
Some college 45.3 29.5 <.001 23.8 <.001 43.1 26.9 <.001 18.9 <.001
College graduate 32.7 31.8 .49 32.9 .92 33.8 34.3 .73 38.2 .005
Employment status
Employed 6.2 49.7 <.001 80.2 <.001 4.6 37.7 <.001 57.5 <.001
Unemployed/able 2.2 3.8 .005 7.7 <.001 1.9 2.9 .07 4.9 <.001
Unemployed/unable 40.7 4.9 <.001 4.3 <.001 38.2 4.5 <.001 7.3 <.001
Retired 50.9 41.6 <.001 7.8 <.001 55.2 54.8 .79 30.3 <.001
Marital status
Married 75.5 72.7 .04 57.4 <.001 77.4 76.7 .61 75.1 .11
Divorced/separated 16.8 12.8 <.001 9.1 <.001 15.7 11.0 <.001 12.5 .002
Widowed 3.1 6.4 <.001 1.4 <.001 3.3 8.3 <.001 4.9 .02
Never married 4.6 8.1 <.001 32.1 <.001 3.7 4.0 .61 7.5 <.001
Geographic region of residence
South 29.5 39.7 <.001 36.4 <.001 28.5 38.3 <.001 37.0 <.001
West 22.9 22.1 .54 23.7 .53 23.7 22.2 .26 21.5 .10
a,b 
cd cd
e
f
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 Unweighted total sample sizes. All data are reported as weighted percentages unless otherwise indicated. 
 Item response for all variables was ≥96%. 
 Significance indicated for male veterans with MS vs men in the general veteran population; calculated using Χ  test 
(except for age, which was calculated using t test). 
 Significance indicated for male veterans with MS vs men in the general population; calculated using Χ  test (except for 
age, which was calculated using t test). 
 Race/ethnicity was self-identified. Hispanic ethnicity included any identified race (or none). Other included Asian, Native 
Hawaiian/Pacific Islander, American Indian or Alaska Native, or other. 
 Employed included employed for wages or self-employed; unemployed was categorized as able to work or unable to work. 
 Chronic drinkers were defined as having consumed ≥2 drinks per day in the past 30 days. 
  
Table 2. Prevalence of Chronic Diseases Among Male Veterans With 
Multiple Sclerosis Compared With General Veteran and General 
Populations, United States, 2003-2004
Abbreviations: MS, veterans with multiple sclerosis; GV, general veteran population; GP, general population. 
 Unweighted total sample sizes. Data are reported as weighted percentages.
 Item response for all variables was ≥90%.
 Significance indicated for male veterans with MS vs men in the general veteran population; calculated using Χ  test. 
 Significance indicated for male veterans with MS vs men in the general population; calculated using using Χ  test.  
  
Table 3. Variables Associated With Chronic Diseases in Male Veterans With 
Multiple Sclerosis, United States, 2003-2004 
Midwest 21.1 20.5 .58 20.7 .75 21.7 21.0 .62 21.3 .77
Northeast 26.5 17.7 <.001 19.2 <.001 26.1 18.5 <.001 20.2 <.001
Cigarette smoking status
Current 16.1 22.8 <.001 25.7 <.001 14.0 17.6 .004 18.9 <.001
Past 63.5 46.1 <.001 22.4 <.001 66.9 53.9 <.001 40.3 <.001
Never 20.4 31.1 <.001 51.9 <.001 19.1 28.6 <.001 40.8 <.001
Chronic drinker 2.8 5.6 <.001 7.2 <.001 2.9 4.8 .006 5.1 .003
Chronic Illness
Overall Aged ≥50 Years
MS 
(n = 
1,142)
GV 
(n = 
31,500) P
GP (n = 
68,357) P
MS (n 
= 
962)
GV (n = 
25,055) P
GP (n = 
21,316) P
Coronary heart 
disease
10.5 11.5 .30 3.3 <.001 12.1 15.0 .01 9.4 .007
Diabetes 15.9 13.6 .02 5.6 <.001 17.8 16.7 .37 14.5 .004
Hypercholesterolemia 48.5 44.6 .008 30.9 <.001 49.7 48.6 .49 44.8 .002
Hypertension 46.7 41.2 <.001 20.9 <.001 49.9 48.1 .26 42.1 <.001
Stroke 7.0 4.2 <.001 1.4 <.001 7.9 5.3 <.001 4.1 <.001
Variable
Diabetes,  
OR (95% 
CI) P
Hypertension,  
OR (95% CI) P
Hyperchol-
esterolemia,  
OR (95% CI) P
Stroke,  
OR (95% 
CI) P
Age 1.03 (1.00-
1.05)
.03 1.02 (1.00-1.03) .06 0.99 (0.97-1.00) .10 1.03 (0.99-
1.07)
.15
Race/ethnicity
Non-Hispanic white 1  NA 1 [Reference] NA 1 [Reference] NA 1  NA
g
a
b
c 2
d 2
e
f
g
a,b 
cd cd
a  
b 
c 2
d 2
a
aa
a
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Non-Hispanic 
black/African 
American
2.78 (1.26-
6.12)
.01 0.93 (0.48-1.81) .83 0.51 (0.26-1.00) .05
1.04 (0.32-
3.32)
.95 Hispanic, any race 1.69 (0.54-
5.29)
.37 0.63 (0.25-1.55) .31 0.63 (0.27-1.47) .28
Other 1.88 (0.36-
9.90)
.46 1.09 (0.31-3.93) .89 0.71 (0.21-2.45) .59
Age at MS 
diagnosis
1.00 (0.98-
1.01)
.59 1.01 (0.99-1.02) .53 1.00 (0.99-1.02) .61 1.03 (1.00-
1.06)
.07
Education completed
<12 y 1 
[Reference]
NA 1 [Reference] NA 1 [Reference] NA 1 
[Reference]
NA
12 y/equivalent 0.73 (0.29-
1.83)
.50 1.34 (0.59-3.05) .48 1.03 (0.46-2.31) .95 0.55 (0.11-
2.63)
.45
Some college 0.54 (0.23-
1.29)
.17 1.08 (0.49-2.38) .84 1.41 (0.65-3.05) .39 0.54 (0.13-
2.18)
.38
College graduate 0.32 (0.13-
0.79)
.01 1.08 (0.49-2.39) .85 1.33 (0.61-2.90) .48 0.84 (0.21-
3.32)
.80
Employment status
Employed 1 
[Reference]
NA 1 [Reference] NA 1 [Reference] NA 1 
[Reference]
NA
Unemployed/able 1.94 (0.47-
8.03)
.36 0.41 (0.13-1.27) .12 2.01 (0.69-5.88) .20 NA NA
Unemployed/unable 1.04 (0.43-
2.55)
.92 1.03 (0.58-1.83) .92 1.10 (0.63-1.94) .74 NA NA
Retired 1.02 (0.42-
2.52)
.96 1.03 (0.58-1.85) .91 1.25 (0.70-2.23) .45 NA NA
Marital status
Married 1 
[Reference]
NA 1 [Reference] NA 1 [Reference] NA 1 
[Reference]
NA
Divorced/separated 0.82 (0.47-
1.44)
.49 0.96 (0.65-1.41) .83 0.83 (0.56-1.21) .33
1.17 (0.50-
2.70)
.72
Widowed 0.43 (0.12-
1.52)
.19 2.54 (1.02-6.33) .05 2.36 (0.97-5.77) .06
Never married 0.15 (0.02-
1.15)
.07 0.92 (0.46-1.84) .81 0.60 (0.30-1.20) .15
Geographic region of residence
South 1 
[Reference]
NA 1 [Reference] NA 1 [Reference] NA 1 
[Reference]
NA
West 0.73 (0.42-
1.26)
.26 1.02 (0.69-1.49) .94 0.90 (0.61-1.31) .57 0.47 (0.18-
1.26)
.13
Midwest 0.61 (0.35-
1.08)
.09 1.11 (0.75-1.65) .60 0.57 (0.39-0.85) .006 0.84 (0.34-
2.06)
.69
Northeast 1.07 (0.65-
1.74)
.80 0.81 (0.56-1.17) .27 0.86 (0.60-1.24) .42 0.55 (0.22-
1.41)
.22
Cigarette smoking status
Current 1 
[Reference]
NA 1 [Reference] NA 1 [Reference] NA 1 
[Reference]
NA
b
b
cc
cc
cc
b
b
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Abbreviations: OR, odds ratio; CI, confidence interval; NA, not applicable; MS, multiple sclerosis; CHD, coronary heart 
disease. 
 Sample size for diabetes, hypertension, and hypercholesterolemia was n = 943; stroke, n = 950. 
 Combined variable categories for inclusion in stroke regression model due to small cell sizes. For race, combined non-
Hispanic black/African American, Hispanic, and other because n <5 for each and for marital status combined never married 
(n = 2) and widowed (n = 6) with divorced/separated. 
 Unable to include employment status and chronic drinker in the stroke regression model due to inadequate cell sizes. (Of 
persons with stroke, only 2 chronic drinkers and only 2 in the employed reference group). 
Past 1.90 (1.00-
3.58)
.05 1.16 (0.77-1.74) .49 0.78 (0.52-1.17) .23 0.60 (0.22-
1.63)
.31
Never 1.15 (0.54-
2.46)
.72 1.15 (0.72-1.86) .56 0.70 (0.44-1.12) .14 0.80 (0.27-
2.42)
.69
Chronic drinker 1.32 (0.40-
4.29)
.65 2.65 (1.00-7.03) .05 1.72 (0.64-4.58) .28 NA NA
Asthma 1.10 (0.51-
2.36)
.81 0.93 (0.53-1.64) .81 1.14 (0.65-1.99) .64 5.18 (2.11-
12.73)
<.001
CHD 1.44 (0.80-
2.62)
.23 1.92 (1.13-3.25) .02 3.17 (1.82-5.52) <.001 5.78 (2.65-
12.61)
<.001
Diabetes NA NA 2.11 (1.42-3.13) <.001 2.15 (1.44-3.21) <.001 3.07 (1.44-
6.54)
.004
Hypertension 2.15 (1.45-
3.19)
<.001 NA NA 1.81 (1.37-2.40) <.001 2.38 (1.14-
4.95)
.02
Hyperchol-
esterolemia
2.16 (1.45-
3.24)
<.001 1.81 (1.37-2.39) <.001 NA NA 0.43 (0.21-
0.89)
.02
Stroke 3.11 (1.46-
6.63)
.003 2.54 (1.19-5.41) .02 0.43 (0.21-0.89) .02 NA NA
cc
a
b
c
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